Rossari Biotech Q2 Results FY26: Q2 PAT Rises 4.37% to ₹36.88 Crore; Revenue Up 17.61% YoY

October 16, 2025
Posted by: sachet
Category: News

Click and Sign Up to Get Live Updates on Q2 Results

Rossari Biotech Q2 Results FY26: Rossari Biotech posted its Q2 results on 15th October 2025. The company posted robust numbers, with Q2 PAT standing at ₹36.88 crores against revenue of ₹586.11 crores. During Q2 FY26, the profit increase of the company was recorded at 4.37% YoY, and the revenue increase for the same period was 17.61%.

Table of Contents

Rossari Biotech Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹586.11	₹498.35
Profit Before Tax (PBT)	₹73.53	₹66.66
Profit After Tax (PAT)	₹36.88	₹35.33

(Figures in crores)

Rossari Biotech Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹419.51	₹335.99
Profit Before Tax (PBT)	₹51.81	₹45.35
Profit After Tax (PAT)	₹31.25	₹27.42

(Figures in crores)

Rossari Biotech Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

Rossari Biotech clocked Q2 FY26 consolidated revenue of ₹586.11 crores vs ₹335.99 crores.
On the profit front, Rossari Biotech earned a consolidated PAT of ₹36.88 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹35.33 crore.
As per the consolidated figures, the quarterly PAT of Rossari Biotech has increased by 4.37%, and revenue has increased by 17.61% YoY.
Rossari Biotech clocked Q2 FY26 standalone revenue of ₹419.51 crores vs ₹335.99 crores.
On the profit front, Rossari Biotech earned a standalone PAT of ₹31.25 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹27.42 crore.
As per the standalone figures, the quarterly PAT of Rossari Biotech has increased by 13.97%, and revenue has increased by 24.86% YoY.

Rossari Biotech Share Price Performance

On the opening bell of 16th October 2025, the shares of Rossari Biotech opened at ₹673.00 per share. However, the initial gains have surged out as of now, and Rossari Biotech shares are trading at ₹675.00 per share, higher than their opening price.

Considering the long-term performance, Rossari Biotech shares have yielded close to -22.75% returns in the past 1 year, and 5-year returns stand at -12.79%. Over the maximum timeframe, the Rossari Biotech share provided -7.77% returns to investors.

What Analysts Expect Post Q2 Results?

As Rossari Biotech has posted robust Q2 results for FY26, analysts are expecting positive trends in its share price. As per the analysts, Rossari Biotech’s share price could reach ₹710.30 per share in the coming year, and in downtrends, the share price could hit the level of ₹620.90 per share. However, one must ignore the risk of volatility in the stock market and invest in Rossari Biotech’s shares after thorough research.

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!